Pirfenidone has been reported to inhibit EMT in pulmonary fibrosis by regulating the Wnt/GSK-3β/β-catenin and TGF-β1/SMad2/3 signaling pathways [202]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.